Prevalence of peripheral arterial disease in type 2 diabetics in pakistan

Journal of the Pakistan Medical Association

Volumn 61, Issue 7, 2011, Pages 644-648

  Akram, Javed ^a   Aamir, Aziz ul Hassan ^b   Basit, Abdul ^c   Qureshi, Mohammad Saleem ^d   Mehmood, Tariq ^e   Shahid, Syed Khurram ^f   Khoso, Irshad Ahmed ^g   Ebrahim, Muhammad Ashraf ^h   Omair, Aamir ⁱ  

^a Akram Medical Complex ^*  (Pakistan)

^b Postgraduate Medical Institute   (Pakistan)

^c BAQAI MEDICAL UNIVERSITY   (Pakistan)

^d KRL Hospital   (Pakistan)

^e Medicare Hospital   (Pakistan)

^f Department of Endocrinology   (Pakistan)

^g Department of Endocrinology   (Pakistan)

^h Zubaida Medical Center   (Pakistan)

ⁱ ZIAUDDIN UNIVERSITY   (Pakistan)

Author keywords

Ankle brachial index; Pakistan; Peripheral arterial disease; Type 2 diabetes

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE DURATION; DOPPLER FLOWMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PAKISTAN; PARESTHESIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 79959799855     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hiatt WR. Medical treatment of peripheral arterial disease. N Engl J Med 2001; 344: 1608-21
2. Donnelly R. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol. Diab Obes Metab 2002; 4: S20-5.
3. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 3333-41.
4. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-92.
5. Barmett AH, Bradbury AW, Brittenden J, Crichton B, Donnelly R, Homer Vanniasinkam S, et al. The role of cilostazol in the treatment of intermittent claudication. Curr Med Res Opin 2004; 20: 1661-70.
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-312.
7. White C. Intermittent claudication. N Engl J Med 2007; 356: 1241-50
8. International Diabetes Federation. IDF Diabetes Atlas, 4th ed. [Internet]. Brussels, Belgium: International Diabetes Federation, 2009. (Online) (Cited 2010 Dec 29). Available from URL: http://www.diabetesatlas.com/content/prevalenceestimatesdiabetes-mellitu s-dm-2010.
9. Hakeem R, Fawwad A. Diabetes in Pakistan: Epidemiology, determinants and prevention. Journal of Diabetology 2010; 3: 4.
10. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality - The Whitehall Study. Circulation 1990; 82: 1925-31.
11. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19: 538-45.
12. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating weight management. BMJ 1995; 311: 158-61.
13. Basit A, Hydrie MZI, Hakeem R, Ahmedani MY, Masood Q. Frequency of chronic complications of type II diabetes. J Coll Physicians Surg Pak 2004; 14: 79-83.
14. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States, results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-43.
15. Mohan V, Premalatha G, Sastry NG. Peripheral vascular disease in non-insulin dependent diabetes mellitus in South India. Diabetes Res Clin Pract 1995; 27: 235-40.
16. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JC, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001; 286: 1317-24.
17. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421-31.
18. Hirsch AT, Murphy TP, Lovell MB, Twillman G; Treat-Jacobson D, Harwood EM, et al. Gaps in public knowledge of peripheral arterial disease - the first National PAD public awareness survey. Circulation 2007; 116: 2086-94.